Method for treating neurological conditions and inducing immunosuppression with cephaibols

US7041649B2 · kind B2 · utility

Assignee

• Sanofi-Aventis Deutschland GMBH · DE

Inventors

• Mathias Schiell · Brechen, DE
• Laszio Vertesy · Eppstein, DE
• Joachim Wink · Rödermark, DE
• Brigitte Schlegel · Berlin, DE
• Albert Haertl · Jena, DE
• Udo Graefe · Jena, DE

Key dates

• Filing date: May 21, 2003
• Grant date: May 9, 2006
• Expiry date: May 21, 2023

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K38/10
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Embodiments of the present invention relate to administering cephaibols to treat conditions of the nervous system and to treat those conditions in which suppressing the immune system would have beneficial effect.